{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:58:45Z","timestamp":1789145925420,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-02189-1","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:03:42Z","timestamp":1766981022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Obesity is a major modifiable factor associated with ER-negative breast cancer: epidemiological and mechanistic evidence from a high-risk cohort"],"prefix":"10.1186","volume":"28","author":[{"given":"Naser","family":"Elkum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Saeed","family":"Al-Zahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura N.","family":"Alraouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"AL-Tweigeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelilah","family":"Aboussekhra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"issue":"3","key":"2189_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"2189_CR2","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2189_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-010-0746-x","volume":"120","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Reis-Filho JS, Ellis IO. Combinatorial biomarker expression in breast cancer. Breast Cancer Res Treat. 2010;120(2):293\u2013308.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"2189_CR4","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Th\u00fcrlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24(9):2206\u201323.","journal-title":"Ann Oncol"},{"issue":"5","key":"2189_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.clbc.2020.03.012","volume":"20","author":"AP Sali","year":"2020","unstructured":"Sali AP, Sharma N, Verma A, Beke A, Shet T, Patil A, et al. Identification of luminal subtypes of breast carcinoma using surrogate immunohistochemical markers and ascertaining their prognostic relevance. Clin Breast Cancer. 2020;20(5):382\u20139.","journal-title":"Clin Breast Cancer"},{"key":"2189_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225398","author":"HO Al-Shamsi","year":"2023","unstructured":"Al-Shamsi HO, Abdelwahed N, Abyad A, Abu-Gheida I, Afrit M, Abu ElFuol T, et al. Breast cancer in the Arabian Gulf countries. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15225398.","journal-title":"Cancers (Basel)"},{"key":"2189_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.amsu.2019.11.021","volume":"49","author":"FK Al-Thoubaity","year":"2020","unstructured":"Al-Thoubaity FK. Molecular classification of breast cancer: a retrospective cohort study. Ann Med Surg (Lond). 2020;49:44\u20138.","journal-title":"Ann Med Surg (Lond)"},{"key":"2189_CR8","unstructured":"Council SH: Cancer Incidence Report 2022. In: Riyadh\u2014KSA: National Cancer Center; 2022."},{"issue":"1","key":"2189_CR9","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1038\/s41467-023-39996-z","volume":"14","author":"HL Nguyen","year":"2023","unstructured":"Nguyen HL, Geukens T, Maetens M, Aparicio S, Bassez A, Borg A, et al. Obesity-associated changes in molecular biology of primary breast cancer. Nat Commun. 2023;14(1):4418.","journal-title":"Nat Commun"},{"key":"2189_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051319","author":"E Trevellin","year":"2023","unstructured":"Trevellin E, Bettini S, Pilatone A, Vettor R, Milan G. Obesity, the adipose organ and cancer in humans: association or causation? Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11051319.","journal-title":"Biomedicines"},{"issue":"1","key":"2189_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1186\/1471-2407-14-788","volume":"14","author":"N Elkum","year":"2014","unstructured":"Elkum N, Al-Tweigeri T, Ajarim D, Al-Zahranil A, Bin Amer SM, Aboussekhra A. Obesity is a significant risk factor for breast cancer in Arab women. BMC Cancer. 2014;14(1):788.","journal-title":"BMC Cancer"},{"issue":"1","key":"2189_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41392-023-01376-w","volume":"8","author":"R Ruze","year":"2023","unstructured":"Ruze R, Song J, Yin X, Chen Y, Xu R, Wang C, et al. Mechanisms of obesity\u2014and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. Signal Transduct Target Ther. 2023;8(1):139.","journal-title":"Signal Transduct Target Ther"},{"issue":"9612","key":"2189_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569\u201378.","journal-title":"Lancet"},{"issue":"1","key":"2189_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s44197-025-00376-z","volume":"15","author":"N Elkum","year":"2025","unstructured":"Elkum N, Aboussekhra A, Aboussekhra M, Aldalham H, Alshehri L, Alessy S, et al. Molecular subtypes of breast cancer in Arab women: distribution and prognostic insights. J Epidemiol Glob Health. 2025;15(1):36.","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"2189_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-012-2339-3","volume":"137","author":"M Pierobon","year":"2013","unstructured":"Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(1):307\u201314.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2189_CR16","first-page":"378","volume":"67","author":"M Picon-Ruiz","year":"2017","unstructured":"Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378\u201397.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2189_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.breast.2012.08.005","volume":"22","author":"FP Turkoz","year":"2013","unstructured":"Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, et al. Association between common risk factors and molecular subtypes in breast cancer patients. Breast. 2013;22(3):344\u201350.","journal-title":"Breast"},{"key":"2189_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00359-18","author":"HH Al-Khalaf","year":"2019","unstructured":"Al-Khalaf HH, Ghebeh H, Inass R, Aboussekhra A. Senescent breast luminal cells promote carcinogenesis through interleukin-8\u2014dependent activation of stromal fibroblasts. Mol Cell Biol. 2019. https:\/\/doi.org\/10.1128\/MCB.00359-18.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2189_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41420-024-02151-8","volume":"10","author":"NN Alraouji","year":"2024","unstructured":"Alraouji NN, Colak D, Al-Mohanna FH, Alaiya AA, Aboussekhra A. Endogenous osteoprotegerin (OPG) represses ERalpha and promotes stemness and chemoresistance in breast cancer cells. Cell Death Discov. 2024;10(1):377.","journal-title":"Cell Death Discov"},{"issue":"4","key":"2189_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3896","volume":"15","author":"EC Dietze","year":"2015","unstructured":"Dietze EC, Sistrunk C, Miranda-Carboni G, O\u2019Regan R, Seewaldt VL. Triple-negative breast cancer in African-American women: disparities versus biology. Nat Rev Cancer. 2015;15(4):248\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"2189_CR21","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA. 2006;295(21):2492\u2013502.","journal-title":"JAMA"},{"key":"2189_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00332-18","author":"HH Al-Khalaf","year":"2019","unstructured":"Al-Khalaf HH, Al-Harbi B, Al-Sayed A, Arafah M, Tulbah A, Jarman A, et al. Interleukin-8 activates breast cancer-associated adipocytes and promotes their angiogenesis\u2014and tumorigenesis-promoting effects. Mol Cell Biol. 2019. https:\/\/doi.org\/10.1128\/MCB.00332-18.","journal-title":"Mol Cell Biol"},{"key":"2189_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1217875","volume":"14","author":"BM Sankofi","year":"2023","unstructured":"Sankofi BM, Valencia-Rincon E, Sekhri M, Ponton-Almodovar AL, Bernard JJ, Wellberg EA. The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism. Front Endocrinol (Lausanne). 2023;14:1217875.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2189_CR24","first-page":"935","volume":"7","author":"H Sun","year":"2017","unstructured":"Sun H, Zou J, Chen L, Zu XY, Wen GB, Zhong J. Triple-negative breast cancer and its association with obesity (Review). Mol Clin Oncol. 2017;7(6):935\u201342.","journal-title":"Mol Clin Oncol"},{"key":"2189_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2024.100106","volume":"10","author":"D Anazco","year":"2024","unstructured":"Anazco D, Acosta A, Cathcart-Rake EJ, D\u2019Andre SD, Hurtado MD. Weight-centric prevention of cancer. Obesity Pillars. 2024;10:100106.","journal-title":"Obesity Pillars"},{"issue":"7","key":"2189_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21305","volume":"7","author":"L Wang","year":"2024","unstructured":"Wang L, Xu R, Kaelber DC, Berger NA. Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes. JAMA Netw Open. 2024;7(7):e2421305.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2189_CR27","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1111\/dom.16489","volume":"27","author":"GA Silverii","year":"2025","unstructured":"Silverii GA, Marinelli C, Bettarini C, Del Vescovo GG, Monami M, Mannucci E. GLP-1 receptor agonists and the risk for cancer: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2025;27(8):4454\u201368.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2189_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33(4):304\u201311.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2189_CR29","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41416-024-02827-z","volume":"131","author":"B Arun","year":"2024","unstructured":"Arun B, Couch FJ, Abraham J, Tung N, Fasching PA. BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing. Br J Cancer. 2024;131(9):1400\u201314.","journal-title":"Br J Cancer"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02189-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02189-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02189-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:44:05Z","timestamp":1769697845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-025-02189-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2189"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02189-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7617890\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at King Faisal Specialist Hospital & Research Centre (RAC#2031091 and RAC#2140017). Written informed consent was obtained from all participants and tissue donors in accordance with institutional guidelines and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}